iStopMM | International Myeloma Foundation

Dr. Sigrun Thorsteinsdottir abstract on CTPC and Smoldering Multiple Myeloma

January 2

Circulating Tumor Plasma Cells in the Screened iStopMM Smoldering Multiple Myeloma Cohort

Dr. Ingigerdur Sverrisdottir abstract on Autoimmune Diseases and MGUS

December 23

Autoimmune Diseases Are Not Associated with MGUS: Results of the Population-Based iStopMM

Dr. Jonsdottir abstract on Hypercalcemia in Individuals with MGUS

December 23

Hypercalcemia in Individuals with MGUS: Results from the iStopMM Study

Jon Oskarsson on Hemodilution

December 21

Determining Hemodilution in Diagnostic Bone Marrow Samples in Multiple Myeloma and Its Precursors By Next-Generation Flow Cytometry: iStopMM Study

Dr. Palmason ASH Abstract M-Proteins

December 15

Transient M-Proteins: Epidemiology, Causes, and the Impact of Mass Spectrometry: The iStopMM Study

Pair of scientists analyze data in research lab

Week in Review

December 14

Top Abstracts of Interest at the ASH 2022 Myeloma Sessions

2022 ASH Abstracts Preview

Week in Review

November 10

A Big Picture Preview of the 2022 ASH Annual Meeting

IMF 6th Annual Asian Myeloma Network Summit

Week in Review

October 20

The IMF’s 6th Annual Asian Myeloma Network Summit in Singapore: A Major Success

blood testing lab

Week in Review

September 14

Myeloma Moonshot: Ahead of Schedule

2022-imwg-summit-meets-in-vienna-1050

Week in Review

June 16

Key Takeaways from the 2022 IMWG Summit

ASH 2021 Stephen Harding Binding Site and iStopMM

January 27

Updates on the Binding Site's ongoing collaboration with the iStopMM study

ASH 2021 Sigurdur Kristinsson First Results from the iStopMM study

January 26

Screening for Monoclonal Gammopathy of Undetermined Significance: First Results from the iStopMM Study

Subscribe to iStopMM

Give Where Most Needed